So, since P1 had a high clinical suspicion for NPC, as demonstrated in the clinical manifestation timeline (Figure 1b) and one positive biomarker (filipin staining), we decided to further investigate the novel NPC1 variants. This evidence concerns the gene NPC1 and nasopharyngeal carcinoma.